Impel Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 3.03, this represents a new company high. This is a clear indication for improving liquidity at Impel Pharmaceuticals Inc 's clients. Average receivable collection period, for the Impel Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 120 days, compared to 129 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 559 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 3146 to 3605.

What is Receivable Turnover Ratio?
What is Impel Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMPL Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	7.46 %	41.86 %	61.61 %	450.59 %	524.77 %
Y / Y Revenue Change	55.52 %	127.04 %	148.55 %	767.94 %	3286.81 %
Receivable Turnover Ratio (TTM)	3.03	2.83	2.48	2.27	2.03
IMPL's Total Ranking	# 3605	# 3146	# 3146	# 3128	# 3128
Accounts Receivable average collection period days	120	129	147	160	179
Seq. Receivable Change	-3.16 %	8.3 %	-15.64 %	21.46 %	27.85 %
Seq. Revenue Change	-24.69 %	45.56 %	-12.7 %	62.49 %	9.95 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 196
Healthcare Sector	# 560
Overall Market	# 3605

Receivable Turnover Ratio Statistics
High	Average	Low
3.03	2.42	1.9
(Sep 30 2023)		(Jun 30 2022)

IMPL Company Profile • Back to IMPL Efficiency Comparisons • Compare IMPL Receivables Turnover Ratio to its Competitors

Financial Statements
Impel Pharmaceuticals Inc 's Accounts Receivable	$ 7 Millions	Visit IMPL's Balance sheet
Impel Pharmaceuticals Inc 's Sales TTM	$ 21 Millions	Visit IMPL's Income Statement
Sources of IMPL's Revenues		Visit IMPL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMPL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMPL's Growth Rates	IMPL's Roa	IMPL's Inventory Turnover Ratio	IMPL's Dividend Comparisons
IMPL's Profitability Ratios	IMPL's Roi	IMPL's Asset Turnover Ratio	IMPL's Dividend Growth
IMPL's Valuation Ratios	IMPL's Roe	IMPL's Financial Strength Ratios	IMPL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Sotera Health Company	8.54	$ 989.752 Millions	$ 115.837 Millions
Zymeworks Inc	8.53	$ 461.579 Millions	$ 54.102 Millions
AnTix Holdings, Inc.	8.53	$ 1.821 Millions	$ 0.214 Millions
Henry Schein Inc	8.53	$ 12,693.000 Millions	$ 1,488.250 Millions
Acadia Healthcare Company Inc	8.49	$ 2,923.743 Millions	$ 344.337 Millions
Adma Biologics Inc	8.48	$ 233.238 Millions	$ 27.518 Millions
Biocorrx Inc	8.45	$ 0.153 Millions	$ 0.018 Millions
Clearpoint Neuro Inc	8.45	$ 22.319 Millions	$ 2.641 Millions
Dynatronics Corporation	8.38	$ 36.828 Millions	$ 4.395 Millions
Silk Road Medical Inc	8.36	$ 169.880 Millions	$ 20.317 Millions
Acadia Pharmaceuticals Inc	8.35	$ 631.886 Millions	$ 75.691 Millions
Harrow Inc	8.29	$ 114.100 Millions	$ 13.772 Millions
Iridex Corp	8.27	$ 53.117 Millions	$ 6.422 Millions
Star Equity Holdings Inc	8.26	$ 63.814 Millions	$ 7.723 Millions
Ati Physical Therapy Inc	8.26	$ 678.488 Millions	$ 82.158 Millions
Pulmatrix Inc	8.25	$ 6.804 Millions	$ 0.824 Millions
Thermogenesis Holdings Inc	8.19	$ 8.112 Millions	$ 0.990 Millions
Lifestance Health Group Inc	8.19	$ 1,004.422 Millions	$ 122.691 Millions
Elutia Inc	8.18	$ 41.536 Millions	$ 5.077 Millions
Halozyme Therapeutics Inc	8.18	$ 780.710 Millions	$ 95.463 Millions
Edwards Lifesciences Corporation	8.15	$ 5,818.600 Millions	$ 713.725 Millions
Idexx Laboratories Inc	8.15	$ 3,587.375 Millions	$ 440.300 Millions
Becton Dickinson And Company	8.11	$ 19,372.000 Millions	$ 2,388.000 Millions
Beone Medicines Ltd	8.08	$ 2,204.465 Millions	$ 272.789 Millions
Atricure Inc	8.08	$ 380.309 Millions	$ 47.061 Millions
Cerus Corporation	8.07	$ 214.720 Millions	$ 26.597 Millions
Cadre Holdings inc	8.05	$ 480.743 Millions	$ 59.721 Millions
Ensign Group Inc	8.04	$ 3,558.509 Millions	$ 442.690 Millions
Veracyte Inc	8.02	$ 343.149 Millions	$ 42.793 Millions
Nephros Inc	7.99	$ 12.528 Millions	$ 1.567 Millions

Date modified: 2026-10-07T00:41:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.